CN1307887A - Medicine composite and its preparation - Google Patents
Medicine composite and its preparation Download PDFInfo
- Publication number
- CN1307887A CN1307887A CN 00136175 CN00136175A CN1307887A CN 1307887 A CN1307887 A CN 1307887A CN 00136175 CN00136175 CN 00136175 CN 00136175 A CN00136175 A CN 00136175A CN 1307887 A CN1307887 A CN 1307887A
- Authority
- CN
- China
- Prior art keywords
- juice
- preparation
- pharmaceutical compositions
- rhizoma chuanxiong
- cortex lycii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a medicine composition and its preparation method. Said invented medicine is made of three Chinese medicinal materials of lycium root bark, ligusticum root and cnidium seed through the processes of adding proper quantity of water, reasonable proportioning, soaking, heating at twice and filtering to obtain the invented liquid preparation for curing the diseases of trachitis, angiitis and arthritis. It is simple in preparation process, non-toxic, and has no toxic side effect, and its cure rate is high.
Description
The present invention relates to a kind of pharmaceutical composition.Be the Chinese patent medicine of feedstock production specifically, the invention still further relates to the preparation method of this medicine with the Chinese herbal medicine.
Tracheitis, vasculitis and arthritis are the common frdquently encountered diseases of serious harm human health, if treat tracheitis, vasculitis and arthritic drug main oral agents at present, defective is that cure rate is low, easily recurrence.
The object of the present invention is to provide a kind of pharmaceutical composition and this preparation of drug combination method, treat tracheitis, vasculitis and arthritis, overcome the deficiency of conventional medicament.
Solution of the present invention is based on motherland's medical science to tracheitis, vasculitis and arthritic pathogenetic understanding and Therapeutic Principle, with reference to the modern pharmacological research achievement, by the theory of Chinese medical science prescription, makes medicine of the present invention.
Pharmaceutical composition of the present invention is made by following component: (consumption is a weight portion)
Cortex Lycii 3-30 Rhizoma Chuanxiong 3-20 Fructus Cnidii 3-25
As improvement, the formulation weight of pharmaceutical composition of the present invention (part) ratio range is:
Cortex Lycii 10-25 Rhizoma Chuanxiong 5-15 Fructus Cnidii 10-20
Optimization formula weight (part) ratio range of pharmaceutical composition of the present invention is:
Cortex Lycii 12-20 Rhizoma Chuanxiong 5-12 Fructus Cnidii 10-15
The production method that above-mentioned each component is made pharmaceutical composition of the present invention is:
(1) Cortex Lycii, Fructus Cnidii, Rhizoma Chuanxiong are taken by weighing by described weight portion proportioning after, add 180-1500 part water purification and soaked 1-2 hour;
(2) heated 1-2 hour down at 90-100 ℃;
(3) leach juice with the 50-80 mesh sieve, as juice A;
The filtering residue of three kinds of Chinese medicines that (4) will filter out adds warm water 120-1000 part water of 50-80 ℃, soaks 5-15 minute;
(5) above-mentioned soaked filtering residue liquid heated 0.5-1 hour down at 90-100 ℃, leached juice with the 50-80 mesh sieve, and mixed with juice A;
(6) mix the juice cooling; Every bottle of 30ml is a fractional pack.
The shelf-life of medicine of the present invention is 2 years.
Pharmaceutical composition of the present invention is a said dosage form in the pharmaceutics.
As improvement, the dosage form of pharmaceutical composition of the present invention is a water preparation.
Smearing the illing skin surface with pharmaceutical composition water preparation of the present invention treats, can treat 1-2 time every day, carry out according to arthritis, vasculitis and arthritic area, put on the skin with absorbent cotton in skin outside and to get final product, about 1 patient needs water preparation 30-60ml, and the lighter uses the 30ml water preparation 7 days course of treatment, 2 recoveries from illness course of treatment of heavy person, effective percentage 85%, cure rate 75%.
The composition of medicine of the present invention and effect are:
Cortex Lycii contains compositions such as betanin Saponin, activating blood circulation to dissipate blood stasis, and be used to disappear eliminating the pathogens from the lung heat, dyspnea and cough due to lung-heat have analgesic antiinflammation, and phlegm and relieving cough, analgesia, antibacterial and anti-inflammation functions are arranged, and external is best.
The Fructus Cnidii warming the kidney to activate YANG is used for chills and pain of the waist and kness, and influenza virus is had inhibitory action, also have that the town is painful, local anesthesia, antipruritic, cough-relieving, remove expectorant, the effect of dispeling the wind.
Rhizoma Chuanxiong contains volatile oil component, wind-expelling pain-stopping, and antithrombotic forms, and coronary blood flow increasing has the microcirculation improvement effect, and antipyretic analgesic, blood-activating and qi-promoting, wind-expelling pain-stopping effect are arranged.
Cortex Lycii, Fructus Cnidii, three kinds of Chinese medicines of Rhizoma Chuanxiong all have activating blood circulation to dissipate blood stasis, the painful cough-relieving in town, analgesicly go to ache, antiinflammation, and three kinds of compound external curing tracheitiies of Chinese medicine, vasculitis, arthritis have good effect.
The clinical use result of pharmaceutical composition of the present invention shows that following advantage is arranged: this medicine is a Chinese medicine preparation, is used for the illing skin surface outward, and nontoxic, side effect is safe and convenient to use; Used raw material of Chinese medicine kind is fewer, and preparation method is comparatively simple.
For showing pharmaceutical composition of the present invention to treatment tracheitis, vasculitis, arthritic therapeutic effect, the present invention is through 53 routine system clinical treatments, wherein male 36 examples, women 17 examples, 1-2 the course of treatment.
Administrated method: every day 1-2 time, each 1-1.5 hour.
Embodiments of the invention are provided below
Embodiment
Take by weighing raw material (gram) by following proportioning:
Cortex Lycii 18 Rhizoma Chuanxiongs 15 Fructus Cnidiis 15
Production method is as follows:
(1) Cortex Lycii, Fructus Cnidii, Rhizoma Chuanxiong are taken by weighing by described weight portion proportioning after, add 960 grams
Water purification soaked 1.5 hours;
(2) heated 1.5 hours down at 90-100 ℃;
(3) leach juice with the 50-80 mesh sieve, as juice A;
The filtering residue of three kinds of Chinese medicines that (4) will filter out adds 60 ℃ warm water 640 gram water, soaks 10 minutes;
(5) above-mentioned soaked filtering residue liquid was heated 1 hour down at 90-100 ℃, use the 50-80 mesh sieve
Leach juice, and mix with juice A.
(6) will mix the juice cooling;
(7) every bottle of 30ml is a fractional pack.
Treatment tracheitis of the present invention, vasculitis, arthritic some cases are provided below.
Case 1 Zhu Yonglin man 51 years old, people from Heilongjiang Province suffered from vasculitis more than 20 year, can not stand, and through failing to respond to any medical treatment for many years, carried out the treatment of two courses of treatment in July, 2000, and with medicinal agent 50ml of the present invention, originally the vascular of varicose recovers normal, and can run morning.
Case 2 Xu intellectual circle men 36 years old, people from Heilongjiang Province, suffering from asthma anaphylaxis tracheitis has 15 years, and can not go out winter, and hospitalization is invalid several times, with medicinal agent 60ml treatment of the present invention recovery from illness in 16 days.
Case 3 Wang Ying woman 52 years old, people from Jilin Province suffers from arthritis for many years, can not go to work in the time of 45 years old, fails to respond to any medical treatment through many-side, and in May, 1998 is with fully recovering around the medicinal agent 90ml treatment of the present invention.
Claims (6)
1 one kinds of pharmaceutical compositions is characterized in that it is the medicament of being made by the following weight proportion raw material
Cortex Lycii 3-30 Rhizoma Chuanxiong 3-20 Fructus Cnidii 3-25
2 pharmaceutical compositions according to claim 1, wherein the weight proportion of each raw material is
Cortex Lycii 10-25 Rhizoma Chuanxiong 5-15 Fructus Cnidii 10-20
3 pharmaceutical compositions according to claim 1, wherein the weight proportion of each raw material is
Cortex Lycii 12-20 Rhizoma Chuanxiong 5-12 Fructus Cnidii 10-15
4 according to claim 1,2 or 3 described pharmaceutical compositions, it is characterized in that said medicament is pharmaceutically said dosage form.
5 pharmaceutical compositions according to claim 4 is characterized in that said medicament is a water preparation.
The described preparation of drug combination method of 6 claim 5 is characterized in that
(1) Cortex Lycii, Fructus Cnidii, Rhizoma Chuanxiong are taken by weighing by described weight portion proportioning after, add 180-1500 part water purification and soaked 1-2 hour;
(2) heated 1-2 hour down at 90-100 ℃;
(3) leach juice with the 50-80 mesh sieve, as juice A;
The filtering residue of three kinds of Chinese medicines that (4) will filter out adds warm water 120-1000 part water of 50-80 ℃, soaks 5-15 minute;
(5) above-mentioned soaked filtering residue liquid heated 0.5-1 hour down at 90-100 ℃, leached juice with the 50-80 mesh sieve, and mixed with juice A;
(6) mix the juice cooling and make water preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001361759A CN1163258C (en) | 2000-12-27 | 2000-12-27 | Medicine composite and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001361759A CN1163258C (en) | 2000-12-27 | 2000-12-27 | Medicine composite and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1307887A true CN1307887A (en) | 2001-08-15 |
CN1163258C CN1163258C (en) | 2004-08-25 |
Family
ID=4597109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB001361759A Expired - Fee Related CN1163258C (en) | 2000-12-27 | 2000-12-27 | Medicine composite and its preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1163258C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003053167A1 (en) * | 2001-12-11 | 2003-07-03 | Societe Des Produits Nestle S.A. | Composition for promotion of bone growth and maintenance of bone health |
CN103301260A (en) * | 2013-05-27 | 2013-09-18 | 布焕景 | External use medicine for treating arthritic and preparation method thereof |
CN104027641A (en) * | 2014-06-04 | 2014-09-10 | 烟台瑞智生物医药科技有限公司 | Traditional Chinese medicine for treating damp heat syndrome type angiitis |
-
2000
- 2000-12-27 CN CNB001361759A patent/CN1163258C/en not_active Expired - Fee Related
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003053167A1 (en) * | 2001-12-11 | 2003-07-03 | Societe Des Produits Nestle S.A. | Composition for promotion of bone growth and maintenance of bone health |
EP1325681A1 (en) * | 2001-12-11 | 2003-07-09 | Société des Produits Nestlé S.A. | Composition for promotion of bone growth and maintenance of bone health |
EP2135517A1 (en) * | 2001-12-11 | 2009-12-23 | Société des Produits Nestlé S.A. | Composition for promotion of bone growth and maintenance of bone health |
EP2263480A1 (en) * | 2001-12-11 | 2010-12-22 | Société des Produits Nestlé S.A. | Composition for promotion of bone growth and maintenance of bone health, comprising Mentha extracts |
EP2272382A1 (en) * | 2001-12-11 | 2011-01-12 | Société des Produits Nestlé S.A. | Composition for promotion of bone growth and maintenance of bone health, comprising soybean or soybean extracts |
EP2286675A1 (en) * | 2001-12-11 | 2011-02-23 | Société des Produits Nestlé S.A. | Composition for promotion of bone growth and maintenance of bone health |
CN103301260A (en) * | 2013-05-27 | 2013-09-18 | 布焕景 | External use medicine for treating arthritic and preparation method thereof |
CN104027641A (en) * | 2014-06-04 | 2014-09-10 | 烟台瑞智生物医药科技有限公司 | Traditional Chinese medicine for treating damp heat syndrome type angiitis |
Also Published As
Publication number | Publication date |
---|---|
CN1163258C (en) | 2004-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1814245A (en) | Chinese medicine remedy for treating cervical vertebra disease | |
CN1502350A (en) | Traditional Chinese medicine composition (Fujangtieda liquor) for curing traumatic injury | |
CN1899518A (en) | External use Chinese medicine for treating burn and scold and its preparing method | |
CN1163258C (en) | Medicine composite and its preparation | |
CN1251736C (en) | Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method | |
CN1074676C (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
CN1772204A (en) | Quick acting analgetic Chinese medicine liquid | |
CN1478525A (en) | Medicated wine for treating traumatic injury | |
CN107050242B (en) | Traditional Chinese medicine composition for treating acute soft tissue injury, preparation method and application thereof | |
CN1895593A (en) | Medicine for treating acne and its preparation | |
CN1530122A (en) | Chinese medicine for treating injury | |
CN1229118C (en) | Bone setting medicine | |
CN1297309C (en) | External medicine composition for curing arthralgia-syndrome of joint and preparation process thereof | |
CN1490018A (en) | Medicine for treating rheumatic disease | |
CN111700977B (en) | Traditional Chinese medicine composition for promoting fracture healing and preparation method and application thereof | |
CN110946903B (en) | Traditional Chinese medicine composition for preventing and treating systemic sclerosis and application thereof | |
CN102319324A (en) | Medicine for treating beriberi | |
CN1143684C (en) | Medicine for treating hypertension and heart disease and its preparation | |
CN1085093C (en) | Traditional Chinese medicine oral liquor for treating male infertility | |
CN1273167C (en) | Medicine for external application for curing rheumatism and its preparation method | |
CN1086140C (en) | Cleaning liquid for treating tinear and its preparing process | |
CN1060394C (en) | Process for preparing prescription and medicinal extract of plaster for activating meridians | |
CN1090196A (en) | Liquid for curing bone fracture | |
CN1121225C (en) | A Chinese medicinal composition for treating hepatitis | |
CN1132588C (en) | Chinese patent medicine for treating gastrosis and its preparing process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |